03:41 PM EST - Labopharm Inc. : announced that it has commenced mailing the Notice of Special Meeting of Shareholders and Management Information Circular to all shareholders of record on August 30, 2011, in preparation for the special meeting to be held on Wednesday, October 5, 2011 at Labopharm's head office in Laval, Quebec. As announced on August 17, 2011, the Meeting will take place to consider, and, if deemed advisable, pass a special resolution approving a plan of arrangement by which Chimigen Inc., a wholly-owned subsidiary of Paladin Labs Inc., will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash. Labopharm Inc.
shares T.DDS are trading even at $0.28.
